Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
246.05
+1.56 (0.64%)
Apr 20, 2026, 2:46 PM EDT - Market open
Ascendis Pharma Market Cap
The market cap or net worth for Ascendis Pharma is currently unavailable.
Market Cap
n/a
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$246.05
Market Cap Chart
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 15.01B | 15.18% |
| Dec 31, 2025 | 13.03B | 64.48% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roivant Sciences | 21.35B |
| Moderna | 21.30B |
| Summit Therapeutics | 19.50B |
| Incyte | 19.47B |
| Genmab | 17.49B |
| BridgeBio Pharma | 14.88B |
| Jazz Pharmaceuticals | 12.52B |
| Ionis Pharmaceuticals | 12.51B |